With data from 1985 to 2025 showing cases of type 1 diabetes on the rise globally, and that incidence of the chronic autoimmune disease is disproportionately higher among persons from lower-income countries, experts of a new study in Diabetes Research and Clinical Practice highlight the importance of new epidemiological studies for inroads to care.1 The … Read more
Key Points Infants born to mothers with pregestational diabetes face a higher risk of NICU admission. Research highlights teh importance of managing diabetes during pregnancy. Understanding risk factors can improve neonatal care and outcomes. New Study Links Pregestational Diabetes to Increased NICU Admissions Updated May 22, 2025 A recent study published in the European … Read more
A groundbreaking clinical trial for the new immunotherapy drug to treat Type 1 diabetes (T1D) has begun in Australia. Led by the University of Queensland’s research facility, Frazer Institute, the trial examining the drug ASITI-201 is the first of its kind in the world and has already dosed its first five participants. The trial is … Read more
Over a span of several months, I helped care for three separate patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors for at least the past 2 years who presented to the ICU with euglycemic diabetic ketoacidosis (DKA) within a few weeks of initiating a keto diet. These days, SGLT2 inhibitors are being prescribed so frequently, it sometimes … Read more
The increasing use of technology for treating type 1 diabetes (T1D) has improved glycemic control; however, it hasn’t eliminated the risk for diabetic ketoacidosis (DKA). In fact, without early recognition, insulin pump malfunctions can directly lead to DKA. Currently, patients test ketones at home using urine test strips that measure acetoacetate (the primary ketone body) … Read more
TOPLINE: The prevalence of cerebral small vessel disease (CSVD) nearly doubled over 7.5 years in neurologically asymptomatic patients with type 1 diabetes (T1D). The progression of cerebral microbleeds (CMBs), one of the manifestations of CSVD, was associated with baseline systolic blood pressure and A1c among other factors, while the progression of white matter hyperintensities was … Read more
This transcript has been edited for clarity. As many of us know, there is a therapy for cancer, known as immune checkpoint inhibitors, that in addition to treating cancer can also cause new-onset type 1 diabetes. I’ve always been interested in this because I don’t really understand what’s happening, and also because patients who develop … Read more
Estimation of cardiovascular risk (CVR) in individuals living with type 1 diabetes (T1D) was a key topic presented by Sophie Borot, MD, from Besançon University Hospital, Besançon, France, at the 40th congress of the French Society of Endocrinology. Borot highlighted the complexities of this subject, outlining several factors that contribute to its challenges. A Heterogeneous … Read more